Magnetic response artificial cell and application thereof in cerebral hemorrhage
By adding PELA and superparamagnetic iron oxide nanoparticles to the PLGA scaffold, magnetically responding artificial cells were constructed, and the selection and safety of mitochondrial transplantation were solved, selective enrichment and effective transplantation in the brain were achieved, and the brain was reduced Intrainflammatory promotes the recovery of neurological function and significantly improves the prognosis after ICH.
Patent Information
- Application Number
- CN202411250751.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-08
AI Technical Summary
The existing mitochondrial transplantation technology is difficult to selectively target the site of intracerebral injury, and there are problems with tumorigenic risk and inefficiency, especially in the immune inflammatory response after cerebral hemorrhage.
PLGA is used as the main component of the artificial cell scaffold, PELA and superparamagnetic iron oxide nanoparticles are added, and magnetically responded artificial cell scaffolds are prepared by water-in-oil-in water-in-water dual emulsification method, loading mitochondria, and enriching under magnetic fields using magnetic response characteristics. Into the brain, selective transplantation of mitochondria is achieved.
The self-healing properties of magnetically responded to artificial cells protect mitochondria and avoid external attacks, and selective enrichment and effective transplantation of mitochondria, alleviate intracerebral inflammation, promote the recovery of neurological function, and significantly improve the prognosis after ICH.
Smart Images

Figure CN118903549A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of nano-biomedicine, and in particular relates to a magnetically responsive artificial cell and an application thereof in cerebral hemorrhage. Background Art
[0002] Intracerebral hemorrhage (ICH) is intracerebral hemorrhage caused by local cerebral blood vessel rupture. It is the type of stroke with the highest mortality and disability rate in clinical practice. One of the main reasons for the poor prognosis of ICH patients is the progression of immune inflammatory response after ICH, which causes secondary brain damage. This damage is difficult to intervene and often affects the surrounding areas of the injury or even the entire brain, leading to extensive neuronal damage. However, due to the non-selective effects of commonly used anti-inflammatory drugs, studies have reported that long-term use can interfere with the ability to regulate blood pressure and increase the risk of rebleeding in patients. At present, there is no clear and effective drug that can target the overactivated immune inflammatory environment in the brain after ICH. Therefore, it is particularly important to explore a treatment method that can selectively target the immune inflammatory response in the brain.
[0003] Microglia (BV2), as the main resident immune cells of the central nervous system, participate in and regulate the inflammatory process in the brain. Proinflammatory microglia play a key role in regulating the brain environment to a proinflammatory state. Impaired mitochondrial (Hmito) function is closely related to the proinflammatory activity of microglia, which in turn exacerbates the progression of brain inflammation after ICH. One of the most promising strategies to correct mitochondrial function is mitochondrial transplantation, which involves transplanting exogenous mitochondria into damaged cells to restore mitochondrial function of damaged cells by directly supplementing or inducing mitochondrial autophagy or mitochondrial generation, and has become a promising way to intervene in the proinflammatory phenotype of immune cells and regulate the immune microenvironment. Therefore, exogenous mitochondrial transplantation is expected to improve the proinflammatory phenotype of microglia, thereby alleviating brain damage secondary to ICH.
[0004] Mitochondrial transplantation can be divided into two categories: direct delivery and indirect delivery. Direct delivery is achieved by directly transplanting naked mitochondria isolated from cells or tissues. However, naked mitochondria are vulnerable to attack or clearance in the circulation and cannot selectively reach the site of injury, which limits their efficacy. Although in situ injection can circumvent these problems, it is difficult to meet the needs of repeated treatment and patient compliance, and the distribution range of mitochondria is also limited. In contrast, the indirect delivery pathway uses cells as donors and carriers of mitochondria, relying on spontaneous mitochondrial transfer between cells for mitochondrial transplantation. Among them, stem cells have the chemotactic properties of the injured site and have become the most commonly used mitochondrial carrier cells. However, because they mainly rely on glycolysis rather than oxidative phosphorylation for energy supply, they show poor mitochondrial respiration and ATP production capabilities, resulting in low efficiency of mitochondrial transfer between cells. In addition, there is also a risk of tumorigenicity. Therefore, it is urgent to develop a safe and non-invasive method for mitochondrial transplantation that allows mitochondria to selectively remain in the lesion brain area to combat the overactivated immune microenvironment in the brain after ICH. Summary of the invention
[0005] The present invention uses PLGA as the main component of the artificial cell (ACs) scaffold, adds PELA to PLGA, and mixes superparamagnetic iron oxide nanoparticles therein to construct a magnetically responsive ACs scaffold, loads mitochondria through the self-healing properties of the scaffold, obtains magnetically responsive ACs, and proves its effectiveness in an ICH animal model. Based on this, the present invention is completed.
[0006] In a first aspect, a method for constructing a magnetically responsive ACs scaffold is provided, the method being obtained by the following steps:
[0007] S1: Mixing the backbone material, emulsifier and magnetic particles; preparing porous microspheres using a water-in-oil-in-water (W / O / W) double emulsification method;
[0008] S2: Regulate its structural properties so that the diameter of the microspheres is maintained at 5-10 microns, the microspheres show multiple open pores on the surface, and have an interconnected porous network inside.
[0009] Furthermore, the main material is PLGA.
[0010] Furthermore, the emulsifier is PELA.
[0011] Furthermore, the magnetic particles are iron particles.
[0012] Furthermore, the iron particles are superparamagnetic iron oxide nanoparticles.
[0013] Furthermore, the inner aqueous phase component is 0.5% physiological saline (w / t) or 0.5% sodium oleate aqueous solution (w / t), preferably 0.5% physiological saline (w / t).
[0014] Furthermore, the external aqueous phase component is a 1.5% PVA aqueous solution (w / t) or a 3.0% PVA aqueous solution (w / t), preferably a 1.5% PVA aqueous solution (w / t).
[0015] Furthermore, the pore evolution time is 60 seconds, 90 seconds and 120 seconds, preferably 90 seconds.
[0016] Further, the microspheres have a diameter of about 6 microns.
[0017] Furthermore, the opening hole has a diameter of about 2 microns.
[0018] In the second aspect, a complex is provided, wherein the complex is composed of a magnetically responsive ACs scaffold and mitochondria, wherein the mitochondria are loaded into the magnetically responsive ACs scaffold, and the magnetically responsive ACs scaffold is obtained by the method described in the first aspect.
[0019] In the third aspect, a magnetically responsive ACs is obtained by incubating a magnetically responsive ACs scaffold obtained by the method described in the first aspect to trigger spontaneous rearrangement of polymer chains so that the scaffold extends and heals, and the magnetically responsive ACs can be enriched under the action of a magnetic field.
[0020] In a fourth aspect, use of the complex described in the second aspect or the magnetically responsive ACs described in the third aspect in the preparation of drugs or reagents for preventing or treating ICH.
[0021] Beneficial Effects
[0022] The present invention uses PLGA as the scaffold of ACs, adds PELA to PLGA, and "self-healing" occurs at a temperature close to the glass transition temperature, closes the pores of the scaffold, and forms a complete cell-like structure, thereby protecting mitochondria from external attack and phagocytosis. In addition, in order to solve the problem that mitochondria cannot be selectively enriched in the brain, ultra-small iron particles are added during the synthesis of the ACs scaffold to obtain magnetic response characteristics. The magnetic response characteristics of ACs are used to achieve the enrichment of loaded mitochondria in the brain. Through the enrichment of ACs in the brain and the mediated mitochondrial transplantation, the recovery of neurological function after ICH is promoted. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 Screening of mitochondrial donor cells and mitochondrial isolation. (A) Quantitative analysis of mitochondrial respiratory function of four types of cells, including basal respiration, maximum respiratory oxygen consumption rate, and ATP production. **P<0.01, ***P<0.001, ****P<0.0001. (B) Representative transmission electron microscopy images of isolated mitochondria.
[0024] Figure 2. Construction of magnetically responsive ACs. (A) Representative SEM and fluorescence microscopy images of magnetically responsive ACs before loading mitochondria. (B) Hydrodynamic diameter distribution of ACs in water, representative SEM images of self-repairing ACs, and fluorescence microscopy images of colocalization of Hmito and microspheres in ACs. (C) Representative SEM and fluorescence microscopy images of collapsed microspheres. Scale bar = 2 μm.
[0025] Figure 3 Transplantation of mitochondria released from ACs (R-Hmito) improves mitochondrial function in microglia, reduces ROS production and restores cellular metabolism. (A) Representative fluorescence microscopy images of BV2 mitochondrial membrane potential (JC-1) after different treatments under H2O2 exposure. Green: JC-1 monomers, representing damaged mitochondria with loss of membrane potential; red: JC-1 aggregates, representing mitochondria with normal membrane potential. Scale bar = 20 μm. (B) Representative oxygen consumption rate (OCR) curves of BV2 cells in different treatment groups. (C) Comparison of BV2 mitochondrial respiratory function after different treatments under H2O2 exposure, including basal respiration and ATP production. (D) The proportion of apoptotic BV2 cells after different treatments under H2O2 exposure by flow cytometry.
[0026] Figure 4 .R-Hmito transplantation improves microglial inflammation. (A) Representative immunofluorescence images of CD206 (green) and iNOS (red) in BV2 cells under different treatments, (B) corresponding quantitative results of mean fluorescence intensity of CD206 and iNOS. *p<0.05, **p<0.01.
[0027] Figure 5 .ACs accumulate in the brain in response to magnetic fields. (A) The ability of ACs to remain in a magnetic field was simulated in an in vitro hemodynamic model. Left: Magnetic responsive ACs are clearly retained in the area with a magnetic field. Right: Non-magnetic responsive ACs pass through the magnetic field area quickly with almost no retention. (B) Representative fluorescence imaging of the distribution of ACs in mouse brain regions at different time points after intravenous injection.
[0028] Figure 6 ACs promote neurological recovery after ICH by reducing brain inflammation and promoting immune homeostasis. (A) Body weight change curve of each group of mice within 7 days after ICH surgery. (B) Garcia score and grip strength test of neurological function of mice on days 3 and 7 after surgery. The lower the score or strength, the more severe the injury. *p<0.05, **p<0.01. (C) Representative gait diagrams and quantitative analysis of mice in each group on the third day after ICH.
[0029] the term:
[0030] PLGA: Poly(lactic-co-glycolicacid), PLGA is one of the most successfully applied biodegradable polymers. Since its hydrolysis metabolites, lactic acid and glycolic acid, are endogenous compounds that can be completely metabolized by the human body through the tricarboxylic acid cycle, PLGA is considered to have extremely low systemic toxicity in drug delivery or biomaterial applications. It is widely used in various medical applications and meets the requirements of safety and biodegradability.
[0031] PELA: A polymer of polylactic acid and polyethylene glycol, which has both hydrophilic and lipophilic properties, and has excellent biocompatibility and biodegradability. It can be used as a sustained-release carrier for a variety of different types of drugs. DETAILED DESCRIPTION
[0032] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in the embodiments described below can be combined with each other as long as they do not conflict with each other.
[0033] The experimental methods in the following examples are conventional methods unless otherwise specified, and the experimental materials used in the following examples are commercially available unless otherwise specified.
[0034] Example 1 Screening of mitochondrial donor cells and isolation of mitochondria
[0035] Microglia are the main immune cells in the brain and play a key role in the development of neuroinflammation after ICH. They present different metabolic states in response to external stimuli. Impaired mitochondrial function and the ensuing dysregulated metabolic state are closely related to the proinflammatory effects of microglia. Mitochondrial transplantation is an innovative strategy to restore mitochondrial metabolic function. Transplantation of mitochondria with different respiratory functions may have different effects on the mitochondrial respiratory function of recipient cells.
[0036] In order to obtain mitochondria with stronger respiratory function, four cell lines with different metabolic preferences were selected for mitochondrial energy metabolism testing, including mouse umbilical cord mesenchymal stem cells (mUC-MSCs), mouse breast adenocarcinoma cell line (4T1), mouse microglial cell line (BV2) and mouse cardiomyocyte cell line (HL-1). The mitochondrial basal respiration, maximum respiratory oxygen consumption rate and ATP production capacity of each cell line were measured.
[0037] Compared with 4T1, mUC-MSCs, and BV2, HL-1 exhibited the most outstanding respiratory capacity, including the highest mitochondrial basal respiration, maximum respiratory oxygen consumption rate, and ATP production capacity ( Figure 1 A). Subsequently, HL-1 was used to isolate mitochondria. Transmission electron microscopy results showed that the isolated mitochondria had a complete outer membrane and recognizable cristae formed by the inner membrane ( Figure 1 B).
[0038] Example 2 Construction of magnetically responsive artificial cells loaded with mitochondria
[0039] Phase I: Porous microspheres were prepared using a water-in-oil-in-water (W / O / W) double emulsification method as scaffolds for ACs. PLGA was used as the main material, 5% (w / t) PELA was mixed as an emulsifier, and superparamagnetic iron oxide nanoparticles (SPIONs) were incorporated into it. Its structural properties can be effectively regulated by controlling the emulsification force, osmotic gradient, and pore evolution time. The diameter of the optimized microspheres was maintained at approximately 6 microns, and the surface of the microspheres showed multiple open pores (about 2 microns in diameter), with an interconnected porous network inside that exceeded the size of exposed mitochondria, allowing mitochondria to diffuse freely into the interior of the microspheres ( Figure 2 A).
[0040] Phase II: Due to the "self-repair" phenomenon of PLGA, gentle incubation triggers the spontaneous rearrangement of the polymer chains, causing the PLGA scaffold to extend and gradually heal the original open holes, thereby encapsulating the mitochondria and forming a complete cell-like structure, the so-called "magnetically responsive artificial cells". The co-localization of mitochondria labeled with Mitotracker Green and microspheres labeled with red fluorescence proves that the mitochondria are successfully loaded and the magnetically responsive ACs are successfully constructed. Figure 2 B).
[0041] Phase III: After successfully constructing magnetically responsive ACs, the kinetics of mitochondrial release were further evaluated. The ACs continued to degrade over time, resulting in the re-exposure of the previously closed pores and the continued release of mitochondria therein ( Figure 2 C).
[0042] Example 3 Mitochondrial transplantation reduces oxidative stress damage in microglia
[0043] In order to simulate the pathological process of oxidative stress injury of immune cells in the brain after ICH, BV2 was first exposed to H2O2 (500 μM) for 2 hours. Subsequently, PBS, mitochondria released by ACs (R-Hmito), and free naked mitochondria without ACs loading (F-Hmito) were added to each group and incubated for another 4 hours. Conventionally cultured BV2 served as a normal control. The loss of mitochondrial membrane potential and abnormally high levels of ROS production are early signs of mitochondrial oxidative damage. After exposure to H2O2 for 8 hours, fluorescence imaging showed that the mitochondrial membrane potential of the PBS group was significantly impaired ( Figure 3 A).
[0044] The most important function of mitochondria is to provide ATP required for cellular activities through the process of oxidative phosphorylation (also known as mitochondrial respiration). Mitochondrial dysfunction directly affects the oxygen consumption rate and ATP production of cells. Similarly, after 2 hours of H2O2 treatment in BV2 cells, PBS, R-Hmito and F-Hmito were added to each group, and incubation continued for 12 hours. Conventionally cultured BV2 served as a normal control. The mitochondrial respiratory function of each group of BV2 was detected by mitochondrial stress test and oxygen consumption rate (OCR) plate analysis. The results showed that when mitochondria were subjected to oxidative stress, the OCR of the cells, the basal respiratory capacity of the cells, and the ATP production were significantly reduced. Transplantation of F-Hmito and R-Hmito significantly enhanced the OCR, basal respiratory capacity and ATP production of damaged BV2 cells ( Figure 3 BC). Flow cytometry was used to measure the proportion of apoptotic BV2 cells in different treatment groups under H2O2 exposure. The results showed that transplantation of F-Hmito and R-Hmito reduced the proportion of BV2 cell apoptosis and improved the cell survival ability ( Figure 3 D).
[0045] Example 4 F-Hmito and R-Hmito transplantation improves microglia-mediated inflammatory response
[0046] The immune status of microglia directly affects the immune microenvironment process after ICH. Healthy mitochondria and enhanced oxidative phosphorylation provide energy for immunosuppressive microglia, while the accumulation of reactive oxygen species (ROS) amplifies the proinflammatory effects of microglia. F-Hmito and R-Hmito transplantation are expected to inhibit the proinflammatory response of microglia and restore their immune balance, thereby regulating the immune microenvironment in the brain. Therefore, we further investigated the effects of F-Hmito and R-Hmito transplantation on the immune status of BV2 microglia.
[0047] The classic lipopolysaccharide (LPS)-induced BV2 inflammation model was used to simulate the inflammatory state occurring in the brain. First, BV2 was stimulated with LPS for 6 hours to simulate the inflammatory environment in the brain. Then each group was treated with PBS, F-Hmito, and R-Hmito and cultured for 24 hours. Conventionally cultured BV2 served as a normal control. The expression levels of iNOS (a proinflammatory phenotype marker) and CD206 (an immunosuppressive phenotype marker) in the different treatment groups were then detected.
[0048] Immunofluorescence images showed that in the PBS group, LPS stimulation led to the enlargement of BV2 cells and a significant increase in iNOS expression. In contrast, CD206 was almost not expressed, indicating that BV2 had polarized toward a pro-inflammatory phenotype. In contrast, both F-Hmito and R-Hmito treatments reduced iNOS expression and upregulated CD206 expression to some extent ( Figure 4 AB).
[0049] Example 5: Accumulation of ACs in the brain under the action of a magnetic field
[0050] To determine whether the designed ACs can successfully deliver isolated mitochondria to the injury site, an in vitro hemodynamic model was used to evaluate the retention capacity of magnetically responsive and non-magnetically responsive ACs under magnetic field conditions ( Figure 5 A). A magnetic field is set on the top of the flat flow chamber, and a microscope is used to observe and record the process of magnetically responsive ACs and non-magnetically responsive ACs passing through the flow chamber with the flowing liquid. The bottom of the flat flow chamber is coated with collagen to simulate the lumen of damaged blood vessels after ICH. Figure 5 As shown on the left side of A, a considerable number of magnetically responsive ACs were obviously retained in the magnetic field region and attached to the simulated blood vessel wall, which may help ACs pass through the damaged blood-brain barrier (BBB) after ICH and subsequently enter the brain parenchyma. In contrast, most of the non-magnetically responsive ACs were carried away by the blood flow and quickly passed through the magnetic field region with almost no retention ( Figure 5 A).
[0051] Subsequently, we evaluated the ability of magnetically responsive ACs to be retained in the brain under magnetic field conditions. Physiological saline, naked Hmito, and ACs were intravenously injected into ICH model mice, and a magnetic field was applied outside the brain for 20 minutes. In vivo fluorescence imaging of mouse brain regions was performed 1, 3, 6, 12, and 24 hours after intravenous injection. The results showed that naked Hmito was present in the brain in very limited amounts, while ACs accumulated rapidly and in large quantities under the action of a magnetic field ( Figure 5 B).
[0052] Example 6 ACs promote functional recovery after ICH
[0053] First, the ICH model was established, and non-standardized ICH mice were excluded by the modified Garcia score on the first day after the ICH modeling surgery to ensure that the disease state in the ICH model before intervention was similar. Sham-operated mice were used as controls (Sham group), and saline, naked Hmito, and mitochondria-loaded ACs were intravenously injected into different groups of ICH model mice. By detecting the weight of mice after surgery, we found that the weight of mice in each group decreased rapidly on the first day after surgery and began to gradually recover on the second day after surgery. Among them, the mice in the ACs group recovered their weight faster than the mice in the saline group and the naked Hmito group, and recovered to their preoperative weight on the sixth day after surgery ( Figure 6 A).
[0054] The recovery of neurological function was evaluated by combining modified Garcia score and various behavioral experiments on the 3rd and 7th days after surgery. Compared with the saline group and the bare Hmito group, the ACs treatment group showed a certain advantage in the modified Garcia score on the third day after surgery, and this advantage was particularly obvious on the 7th day after surgery ( Figure 6 B). In addition, as early as postoperative day 3, mice in the ACs group showed significant improvements in multiple behavioral assessments compared with mice in the saline group. These included increased forelimb strength ( Figure 6 B) more normal gait sequence, shorter strides, and increased gait symmetry when walking ( Figure 6 C). As shown in the footprints of mice in each group on the third day after surgery, the mice in the sham operation group walked lightly and steadily. In contrast, the stride length of the affected limb (left side) of the mice in the saline group was significantly reduced, and they showed lateral swaying, and the symmetry of the left and right footprints was poor; however, the footprints of the affected limbs in the ACs group showed slight lateral swaying, and the gait symmetry was significantly improved ( Figure 6 C). In most of these behavioral test indicators, the ACs group showed advantages over the naked Hmito group in many indicators, especially significantly enhanced upper limb strength and significantly shortened stride length ( Figure 6 C).
Claims
1. A method for constructing a magnetically responsive ACs scaffold, the method comprising the following steps: S1: The backbone material, emulsifier and magnetic particles are mixed to prepare porous microspheres using a water-in-oil-in-water (W / O / W) double emulsification method; S2: Regulate its structural properties so that the diameter of the microspheres is maintained at 5-10 microns, the microspheres show multiple open pores on the surface, and have an interconnected porous network inside.
2. The method according to claim 1, wherein the main material is PLGA, the emulsifier is PELA, and the magnetic particles are iron particles.
3. The method according to claim 1, wherein the iron particles are superparamagnetic iron oxide nanoparticles.
4. The method according to claim 1, wherein the internal aqueous phase component is 0.5% saline (w / t) or 0.5% sodium oleate aqueous solution (w / t), preferably 0.5% saline (w / t).
5. The method according to claim 1, wherein the external aqueous phase component is a 1.5% PVA aqueous solution (w / t) or a 3.0% PVA aqueous solution (w / t), preferably a 1.5% PVA aqueous solution (w / t).
6. The method according to claim 1, wherein the structural characteristics are regulated by controlling the emulsifying force, the osmotic gradient and the pore evolution time, wherein the pore evolution time is 60 seconds, 90 seconds and 120 seconds, preferably 90 seconds.
7. The method of claim 1, wherein the microspheres have a diameter of about 6 microns and the openings have a diameter of about 2 microns.
8. A complex, which is composed of a magnetically responsive ACs scaffold and mitochondria, wherein the mitochondria are loaded into the magnetically responsive ACs scaffold, and the magnetically responsive ACs scaffold is obtained by the method described in the first aspect.
9. A magnetically responsive ACs, wherein the magnetically responsive ACs scaffold obtained by the method described in the first aspect is incubated to trigger the spontaneous rearrangement of polymer chains to extend and heal the scaffold, and the magnetically responsive ACs can be enriched under the action of a magnetic field.
10. Use of the complex according to claim 8 or the magnetically responsive ACs according to claim 9 in the preparation of a drug or reagent for preventing or treating ICH.
